HRQOL in Locally Advanced Thyroid Carcinoma

Clinical trial NCT05824312 · UNKNOWN

Trial details

NCT number: NCT05824312
Sponsor: Fujian Cancer Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Thyroid Cancer Tyrosine Kinase Inhibitor Health Related Quality of Life

Start date: 2023-02-01
Primary completion: 2025-01-31
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.